From the point of view of the real project, understand how ALREG checks the information, collides the application path and advances the agreed compliance. The outcome of the case is described in terms of the identifiable scope.
EXPERIENCE IN PRACTICE
Experience from actual engagements
See the work we have handled, from first-time filings to renewals and record maintenance.
2,600+recorded engagements
5product service categories
Based on historical company engagement records as of October 27, 2026. Counts include renewals, multiple services and possible duplicate records. They do not represent unique customers or FDA approvals.
In a project under which overseas brands commissioned Chinese factories to produce OTC specialized drugs, the registration of the original facility did not accurately reflect the actual surrogate relationship. AlL REG helps to collate and revise corporate roles, Labeler Code and Drug Listing information.
The package consisting of additional fibres and a pattern spray has not been cleared by the cross-border power provider platform due to the fact that the MoCRA declaration did not match the label subject. ALL REG successfully brought on client feedback after checking factory brand information, labels and the listing of two products.
A September 2025 engagement record lists SID. This case distinguishes the work confirmed by the record from the process information typically reviewed for similar food projects.
A cosmetics product in August 2026 has been submitted for registration using the “product register” acronym. The page describes the boundary between this name and the MoCRA product listing that needs to be further checked.
One drug in December 2023 has been registered as an “additional product”. Examples suggest that enterprises distinguish between existing facilities information maintenance, product listing and pharmaceutical listing permits.
A completed record of September 2026, which also records the registration of the medical device and the product listing, shows the difference between the two matters and the pre-checking points for similar items.
2026-07 The registered transactions related to the registration of food facilities. An anonymous compilation of company project files is used to inform the communication of similar needs.
A September 2025 engagement involved food facility registration, FCE and SID. The anonymized project record is provided as a reference for similar inquiries.
A December 2024 engagement involved device establishment registration, device listing and GUDID. The anonymized project record is provided as a reference for similar inquiries.
A May 2026 engagement included services related to a facility and its products. The anonymized project record is provided as a reference for similar inquiries.
2023-12 The completed establishment registration involves the renewal of the pharmaceutical enterprise. An anonymous compilation of company project files is used to inform the communication of similar needs.
2026-09 The completed business register relates to the DMF documentation item. An anonymous compilation of company project files is used to inform the communication of similar needs.
For a project by an anonymous Chinese beverage business to expand the United States market, the product and processing process of combing tea and related beverages will determine the applicability of FCE/SID and support the preparation and submission of information.
A project to expand United States sales channels for an anonymous Chinese skin-care branding company, collating product regulatory properties, facility registers, Responsible Person and product listing information.
In response to a project by an anonymous Chinese pharmaceutical production company to expand the United States market, the relationship between drug listing routes, facility registration, Labeler Code, NDC planning and Drug Listing has been developed.
Anonymized pharmaceutical packaging component project: collating quality information on the new module model, DMF applicability and follow-up maintenance.
Anonymized thermal product project record: first distinguish between medical treatment and radiation-emiting project, then check the facility and file the matter.